Home / TOM1L1 Knockout Cell Lines

TOM1L1 Knockout Cell Lines

Gene: TOM1L1

Official Full Name: target of myb1 like 1 membrane trafficking proteinprovided by HGNC

Gene Summary: Enables clathrin binding activity and protein kinase binding activity. Involved in negative regulation of mitotic nuclear division; positive regulation of protein phosphorylation; and signal transduction. Located in cytosol and endosome. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO32361 TOM1L1 Knockout cell line (HeLa) Human TOM1L1 1:3~1:6 Negative Online Inquiry
KO32362 TOM1L1 Knockout cell line (HCT 116) Human TOM1L1 1:2~1:4 Negative Online Inquiry
KO32363 TOM1L1 Knockout cell line (HEK293) Human TOM1L1 1:3~1:6 Negative Online Inquiry
KO32364 TOM1L1 Knockout cell line (A549) Human TOM1L1 1:3~1:4 Negative Online Inquiry

Background

TOM1L1 Gene Knockout Cell Lines are specially engineered cell lines that have undergone targeted gene deletion of the TOM1L1 gene, a critical component involved in intracellular protein transport and sorting. The knockout of this gene allows researchers to explore its functional role in cellular processes, including vesicular trafficking, endosomal maturation, and protein homeostasis. These cell lines serve as indispensable tools for functional genomics, enabling detailed studies into protein interactions and cellular responses in various physiological and pathological contexts.

The primary mechanism at play in TOM1L1 knockout cell lines is the alteration of the endocytic and exocytic pathways, which leads to disruptions in protein localization and degradation. Researchers can utilize these models to investigate how the absence of TOM1L1 impacts cellular signaling, organelle integrity, and overall cellular health. Such insights are crucial for understanding various diseases, including neurodegenerative disorders and cancer, where protein misfolding and impaired trafficking are common.

Scientifically, the TOM1L1 knockout cell lines find value in both research and clinical settings, providing a significant advancement in the study of gene function. They allow for high-throughput screening applications, facilitating drug discovery and the identification of potential therapeutic targets. Moreover, these cell lines can be applicable in gene therapy studies, where understanding the gene’s role can inform therapeutic strategies for corrective interventions.

The advantages of employing TOM1L1 knockout cell lines lie in their specificity and the precision with which the gene loss is achieved. Unlike alternative general knockout strategies, these lines provide a clean genomic edit with minimal off-target effects, thereby ensuring reliable and reproducible results. Researchers will benefit from the experimental clarity offered by these cell lines, ultimately leading to more robust conclusions and discoveries.

In conclusion, the TOM1L1 Gene Knockout Cell Lines represent a strategic tool for investigating the cellular implications of the TOM1L1 gene, showcasing both versatility and specificity in biological research. Our company prides itself on delivering high-quality, genetically modified cell lines backed by extensive expertise in molecular biology, ensuring that our products meet the rigorous standards required by the scientific community.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.